Optimal sequential therapy for metastatic castration-resistant prostate cancer after androgen receptor pathway inhibitors in the up-front era.

被引：0
|
作者：
Naito, Yushi [1 ]
Nagayama, Jun [2 ]
Sano, Yuta [2 ]
Inoue, Satoshi [2 ]
Matsuo, Kazuna [2 ]
Sano, Tomoyasu [3 ]
Ishida, Shohei [2 ]
Matsukawa, Yoshihisa [2 ]
Kato, Masashi [2 ]
Akamatsu, Shusuke [4 ]
机构：
[1] Nagoya Univ Hosp, Dept Urol, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
[3] Nagoya Univ Hosp, Nagoya, Aichi, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-183-180-5577-2829-12292; 283-183-180-5577-5578; 130-540-543-4790; 261-436-2730; 6; 5; 2; 256; 4; 38092-25779; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [21] The impact of the number of prior androgen receptor pathway inhibitors before cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer
    Taniguchi, Hisanori
    Ikeda, Junichi
    Masuo, Yuki
    Kinoshita, Hidefumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2025,
  • [22] Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
    R Ferraldeschi
    J Welti
    J Luo
    G Attard
    J S de Bono
    Oncogene, 2015, 34 : 1745 - 1757
  • [23] Genistein resists castration-resistant prostate cancer by inhibiting the androgen receptor pathway
    Yu, Xiao-Ping
    Zheng, Lu-Jie
    Yan, Jia-Li
    Luo, Yan
    Song, Xiao-Long
    Fu, Tian-Yu
    Peng, Xiao-Li
    Du, Jing-Chang
    Han, Bin
    Li, Fei
    Zhu, Yan-Feng
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2025,
  • [24] Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer
    Rathkopf, Dana
    Scher, Howard I.
    CANCER JOURNAL, 2013, 19 (01): : 43 - 49
  • [25] Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
    Ferraldeschi, R.
    Welti, J.
    Luo, J.
    Attard, G.
    de Bono, J. S.
    ONCOGENE, 2015, 34 (14) : 1745 - 1757
  • [26] Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration-resistant prostate cancer patients
    Tanegashima, Tokiyoshi
    Shiota, Masaki
    Tsukahara, Shigehiro
    Mutaguch, Jun
    Goto, Shunsuke
    Kobayashi, Satoshi
    Matsumoto, Takashi
    Eto, Masatoshi
    PROSTATE, 2024, 84 (14): : 1329 - 1335
  • [27] Sequential therapy for asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer
    Miller, Kurt
    AKTUELLE UROLOGIE, 2020, 51 (06) : 557 - 561
  • [28] Androgen receptor antagonist Treatment of metastatic castration-resistant prostate cancer Treatment of metastatic breast cancer
    Culig, Zoran
    DRUGS OF THE FUTURE, 2023, 48 (01) : 15 - 21
  • [29] Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy
    De Velasco, Marco A.
    Kura, Yurie
    Sakai, Kazuko
    Hatanaka, Yuji
    Davies, Barry R.
    Campbell, Hayley
    Klein, Stephanie
    Kim, Youngsoo
    MacLeod, A. Robert
    Sugimoto, Koichi
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    JCI INSIGHT, 2019, 4 (17)
  • [30] Influence of Statins on Survival Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Inhibitors
    Henriquez Lopez, I.
    Gomez, J.
    Torres, L.
    Acosta, J.
    Arquez, M.
    LaFuerza, A.
    Martinez, F.
    Miranda, M.
    Arenas, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E278 - E279
12345